Alyssa Morimoto

Safety and efficacy of subcutaneous tocilizumab in adults with systemic sclerosis (faSScinate): a phase 2, randomised, controlled trial

Dinesh Khanna, Christopher P. Denton, Angelika Jahreis et al. · The Lancet · 2016 · 652 citations

Rheumatology, Autoimmune Disease, Systemic Scleroderma +7

Suppression of tumorigenicity of glioblastoma cells by adenovirus-mediated MMAC1/PTEN gene transfer.

I. Wayne Cheney, Duane E. Johnson, M T Vaillancourt et al. · PubMed · 1998 · 190 citations

Transient Transduction, Glioma, Malignant Disease +14

Safety and pharmacodynamics of rontalizumab in patients with systemic lupus erythematosus: Results of a phase I, placebo‐controlled, double‐blind, dose‐escalation study

Jacqueline McBride, Jenny Jiang, Alexander R. Abbas et al. · Arthritis & Rheumatism · 2012 · 183 citations

Association of the interferon signature metric with serological disease manifestations but not global activity scores in multiple cohorts of patients with SLE

William P. Kennedy, Romeo Maciuca, Kristen Wolslegel et al. · Lupus Science & Medicine · 2015 · 150 citations · Full text

Efficacy, Safety, and Pharmacodynamic Effects of the Bruton’s Tyrosine Kinase Inhibitor Fenebrutinib (GDC‐0853) in Systemic Lupus Erythematosus: Results of a Phase II, Randomized, Double‐Blind, Placebo‐Controlled Trial

David Isenberg, Richard Furie, Nicholas S. Jones et al. · Arthritis & Rheumatology · 2021 · 126 citations